- Report
- February 2023
- 15 Pages
United States
From €2743EUR$2,995USD£2,335GBP
- Book
- December 2024
- 1440 Pages
- Book
- April 2020
- 336 Pages
- Book
- April 2017
- 232 Pages
- Book
- November 2011
- 284 Pages
- Book
- April 2010
- 754 Pages
- Book
- December 2011
- 400 Pages
- Book
- January 2021
- 462 Pages

Inflammatory Bowel Disease (IBD) is a group of chronic disorders that cause inflammation of the gastrointestinal tract. It is a major area of focus within the field of Allergy and Immunology, as it is believed that the immune system plays a role in the development and progression of IBD. Symptoms of IBD can include abdominal pain, diarrhea, rectal bleeding, and weight loss. Treatment options include medications, lifestyle changes, and surgery.
IBD is a growing area of research and development, with many companies developing new treatments and therapies. Companies such as AbbVie, Janssen, and Takeda are researching and developing new drugs to treat IBD. Other companies such as Enterome, Immuron, and Seres Therapeutics are developing microbiome-based therapies to treat IBD. Additionally, companies such as Medtronic and Boston Scientific are developing medical devices to treat IBD. Show Less Read more